Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 2
2018 4
2019 4
2020 3
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Diabetes in the UK: 2019.
Whicher CA, O'Neill S, Holt RIG. Whicher CA, et al. Diabet Med. 2020 Feb;37(2):242-247. doi: 10.1111/dme.14225. Diabet Med. 2020. PMID: 31901175
Language matters: a UK perspective.
Lloyd CE, Wilson A, Holt RIG, Whicher C, Kar P; Language Matters Group. Lloyd CE, et al. Among authors: whicher c. Diabet Med. 2018 Dec;35(12):1635-1641. doi: 10.1111/dme.13801. Diabet Med. 2018. PMID: 30103276 Review.
c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells.
Gabryšová L, Alvarez-Martinez M, Luisier R, Cox LS, Sodenkamp J, Hosking C, Pérez-Mazliah D, Whicher C, Kannan Y, Potempa K, Wu X, Bhaw L, Wende H, Sieweke MH, Elgar G, Wilson M, Briscoe J, Metzis V, Langhorne J, Luscombe NM, O'Garra A. Gabryšová L, et al. Among authors: whicher c. Nat Immunol. 2018 May;19(5):497-507. doi: 10.1038/s41590-018-0083-5. Epub 2018 Apr 16. Nat Immunol. 2018. PMID: 29662170 Free PMC article.
The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: Results of a pilot randomized, double-blind, placebo-controlled trial.
Whicher CA, Price HC, Phiri P, Rathod S, Barnard-Kelly K, Ngianga K, Thorne K, Asher C, Peveler RC, McCarthy J, Holt RIG. Whicher CA, et al. Diabetes Obes Metab. 2021 Jun;23(6):1262-1271. doi: 10.1111/dom.14334. Epub 2021 Feb 16. Diabetes Obes Metab. 2021. PMID: 33528914 Clinical Trial.
Publisher Correction: c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells.
Gabryšová L, Alvarez-Martinez M, Luisier R, Cox LS, Sodenkamp J, Hosking C, Pérez-Mazliah D, Whicher C, Kannan Y, Potempa K, Wu X, Bhaw L, Wende H, Sieweke MH, Elgar G, Wilson M, Briscoe J, Metzis V, Langhorne J, Luscombe NM, O'Garra A. Gabryšová L, et al. Among authors: whicher c. Nat Immunol. 2019 Mar;20(3):374. doi: 10.1038/s41590-019-0331-3. Nat Immunol. 2019. PMID: 30733606
15 results